HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Phencarol in the treatment of allergic dermatoses of various pathological mechanisms].

Abstract
Phencarol produced in the USSR is an antihistaminic drug highly effective in allergic dermatoses with the pathological mechanism of humoral and cellular type. The best results were obtained in acute allergic dermatoses and in acute recurrences of chronic allergic diseases. In comparative studies with difergan a greater efficiency of phencarol was noted, which was expressed as a higher proportion regression of lesions and more rapid action of the drug. The duration of phencarol treatment was about 3 weeks, the daily dose was 50-75 mg in adults. The drug was well tolerated.
AuthorsJ Rubisz-Brzezińska, L Brzezińska-Wcisło, E Krauze, J Bergier-Miedzińska
JournalPrzeglad dermatologiczny (Przegl Dermatol) 1989 Jan-Mar Vol. 76 Issue 1 Pg. 39-44 ISSN: 0033-2526 [Print] Poland
Vernacular TitleFenkarol w leczeniu dermatoz alergicznych o róznym patomechanizmie.
PMID2573112 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Benzhydryl Compounds
  • Histamine H1 Antagonists
  • Promethazine
  • quifenadine
Topics
  • Adolescent
  • Adult
  • Aged
  • Benzhydryl Compounds (therapeutic use)
  • Dermatitis (drug therapy, etiology)
  • Female
  • Histamine H1 Antagonists (therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Promethazine (therapeutic use)
  • Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: